• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨Paget病中的听力损失:纯音阈值与耳蜗骨密度之间的关系。

Hearing loss in Paget's disease of bone: the relationship between pure-tone thresholds and mineral density of the cochlear capsule.

作者信息

Monsell E M, Cody D D, Bone H G, Divine G W, Windham J P, Jacobson G P, Newman C W, Patel S C

机构信息

Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, Detroit, MI, USA.

出版信息

Hear Res. 1995 Mar;83(1-2):114-20. doi: 10.1016/0378-5955(94)00196-w.

DOI:10.1016/0378-5955(94)00196-w
PMID:7607977
Abstract

We have developed a unique method of quantitative computed tomography (QCT) that enables measurement of the density of the cochlear capsule in vivo. We performed pure-tone audiometry and QCT on 67 ears from 35 subjects with radiographically confirmed Paget's disease of the skull and on 40 ears from twenty volunteer subjects. The Pearson product-moment correlation coefficients (age- and sex-adjusted) in the group affected by Paget's disease were -0.63 for left ears and -0.73 for right ears for high-frequency air conduction pure-tone thresholds (mean of 1, 2, and 4 kHz) versus cochlear capsule density. Correlation coefficients (age- and sex-adjusted) between cochlear capsule density and air-bone gap (mean at 0.5 and 1 kHz) for the affected group were -0.67 for left ears and -0.63 for right ears. All correlations between hearing thresholds and cochlear capsule density in pagetic subjects were significant at p < 0.001. The regressions were consistent throughout the ranges of hearing level. There were no significant correlations between cochlear capsule mean density and hearing level in the volunteer subjects. These findings demonstrate the feasibility of precise and accurate density measurements in the temporal bone in vivo and support the use of the mean cochlear capsule density as a marker of disease effect. Alteration of cochlear capsule bone density may be related to the mechanisms of hearing loss in Paget's disease of bone.

摘要

我们开发了一种独特的定量计算机断层扫描(QCT)方法,该方法能够在体内测量耳蜗囊密度。我们对35名经影像学证实患有颅骨佩吉特病的受试者的67只耳朵以及20名志愿者受试者的40只耳朵进行了纯音听力测定和QCT检查。在受佩吉特病影响的组中,高频气导纯音阈值(1、2和4 kHz的平均值)与耳蜗囊密度之间的Pearson积矩相关系数(经年龄和性别调整),左耳为-0.63,右耳为-0.73。受影响组中,耳蜗囊密度与气骨导差(0.5和1 kHz处的平均值)之间的相关系数(经年龄和性别调整),左耳为-0.67,右耳为-0.63。佩吉特病受试者的听力阈值与耳蜗囊密度之间的所有相关性在p<0.001时均具有统计学意义。在整个听力水平范围内,回归结果一致。在志愿者受试者中,耳蜗囊平均密度与听力水平之间无显著相关性。这些发现证明了在体内颞骨中进行精确和准确密度测量的可行性,并支持将耳蜗囊平均密度用作疾病影响的标志物。耳蜗囊骨密度的改变可能与骨佩吉特病听力损失的机制有关。

相似文献

1
Hearing loss in Paget's disease of bone: the relationship between pure-tone thresholds and mineral density of the cochlear capsule.骨Paget病中的听力损失:纯音阈值与耳蜗骨密度之间的关系。
Hear Res. 1995 Mar;83(1-2):114-20. doi: 10.1016/0378-5955(94)00196-w.
2
The mechanism of hearing loss in Paget's disease of bone.骨佩吉特病听力丧失的机制。
Laryngoscope. 2004 Apr;114(4):598-606. doi: 10.1097/00005537-200404000-00002.
3
Hearing loss in Paget's disease of bone: evidence of auditory nerve integrity.骨佩吉特病中的听力损失:听神经完整性的证据。
Am J Otol. 1995 Jan;16(1):27-33.
4
Hearing loss in Paget's disease: a temporal bone histopathology study.佩吉特病患者的听力损失:颞骨组织病理学研究。
Otol Neurotol. 2012 Feb;33(2):142-6. doi: 10.1097/MAO.0b013e318241c3bd.
5
Osseo-integration in Paget's disease: the bone-anchored hearing aid in the rehabilitation of Pagetic deafness.佩吉特病中的骨整合:骨锚式助听器在佩吉特病性耳聋康复中的应用
J Laryngol Otol. 2001 Nov;115(11):903-6. doi: 10.1258/0022215011909549.
6
[Secondary hearing impairment due to Paget's disease].[佩吉特病所致继发性听力障碍]
An Otorrinolaringol Ibero Am. 1996;23(4):383-8.
7
In search of pathologic correlates for hearing loss and vertigo in Paget's disease. A clinical and histopathologic study of 26 temporal bones.寻找佩吉特病中听力损失和眩晕的病理关联。对26块颞骨进行的临床和组织病理学研究。
Ann Otol Rhinol Laryngol Suppl. 1990 Mar;145:1-16.
8
Hearing sensitivity and bone mineral density in older adults: the Health, Aging and Body Composition Study.老年人的听力敏感性与骨密度:健康、衰老与身体成分研究
Osteoporos Int. 2005 Dec;16(12):1675-82. doi: 10.1007/s00198-005-1902-8. Epub 2005 May 10.
9
Hearing in Paget's disease of bone.骨Paget病的听力
Acta Otorrinolaringol Esp (Engl Ed). 2019 Mar-Apr;70(2):89-96. doi: 10.1016/j.otorri.2018.04.002. Epub 2018 Jun 5.
10
Hearing loss as a complication of Paget's disease of bone.听力损失作为骨佩吉特病的一种并发症。
J Bone Miner Res. 1999 Oct;14 Suppl 2:92-5. doi: 10.1002/jbmr.5650140219.

引用本文的文献

1
Osteoporosis and hearing loss: findings from the Korea National Health and Nutrition Examination Survey 2009-2011.骨质疏松症与听力损失:来自 2009-2011 年韩国国家健康和营养检查调查的结果。
Braz J Otorhinolaryngol. 2020 May-Jun;86(3):332-338. doi: 10.1016/j.bjorl.2018.12.009. Epub 2019 Feb 18.
2
Association of Bone Mineral Density With Hearing Impairment in Postmenopausal Women in Korea.韩国绝经后女性骨密度与听力障碍的关联。
Clin Exp Otorhinolaryngol. 2016 Dec;9(4):319-325. doi: 10.21053/ceo.2015.01858. Epub 2016 May 3.
3
Environmental cadmium and lead exposures and hearing loss in U.S. adults: the National Health and Nutrition Examination Survey, 1999 to 2004.
美国成年人的环境镉和铅暴露与听力损失:1999 年至 2004 年全国健康和营养调查。
Environ Health Perspect. 2012 Nov;120(11):1544-50. doi: 10.1289/ehp.1104863. Epub 2012 Jul 31.
4
Clinical utility of laser-Doppler vibrometer measurements in live normal and pathologic human ears.激光多普勒振动计测量在正常和病理状态下活人耳中的临床应用。
Ear Hear. 2008 Jan;29(1):3-19. doi: 10.1097/AUD.0b013e31815d63a5.
5
Hearing sensitivity and bone mineral density in older adults: the Health, Aging and Body Composition Study.老年人的听力敏感性与骨密度:健康、衰老与身体成分研究
Osteoporos Int. 2005 Dec;16(12):1675-82. doi: 10.1007/s00198-005-1902-8. Epub 2005 May 10.
6
The mechanism of hearing loss in Paget's disease of bone.骨佩吉特病听力丧失的机制。
Laryngoscope. 2004 Apr;114(4):598-606. doi: 10.1097/00005537-200404000-00002.
7
The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.詹姆斯·佩吉特爵士(1814 - 1894)对风湿性疾病研究的贡献。
Clin Rheumatol. 1996 Sep;15(5):461-72. doi: 10.1007/BF02229643.